Physician Wealth Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Buy
2,070
+128
+7% +$23.2K 0.04% 158
2026
Q1
$286K Buy
1,942
+682
+54% +$111K 0.04% 155
2025
Q4
$246K Sell
1,260
-438
-26% -$104K 0.03% 167
2025
Q3
$478K Sell
1,698
-128
-7% -$32.6K 0.07% 111
2025
Q2
$399K Sell
1,826
-27
-1% -$4.36K 0.06% 118
2025
Q1
$259K Sell
1,853
-93
-5% -$15.1K 0.04% 150
2024
Q4
$324K Buy
1,946
+283
+17% +$50.3K 0.05% 131
2024
Q3
$290K Hold
1,663
0.05% 137
2024
Q2
$237K Hold
1,663
0.04% 155
2024
Q1
$201K Buy
+1,663
New +$190K 0.04% 172

Other funds holding ORCL

Physician Wealth Advisors's ORCL Position: Q2 2026 in Review

Physician Wealth Advisors increased its Oracle (ORCL) stake by 6.6% in Q2 2026, buying an estimated $23.2K and bringing the position to 2,070 shares worth $303K. The position accounts for 0.04% of the portfolio, ranked #158.

Physician Wealth Advisors first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $478K in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Physician Wealth Advisors held 2,070 shares of Oracle worth $303K as of Q2 2026.
  • Physician Wealth Advisors bought 128 Oracle shares in Q2 2026, an estimated $23.2K.
  • Oracle made up 0.04% of Physician Wealth Advisors's portfolio in Q2 2026, its #158 holding.
  • Physician Wealth Advisors first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • Physician Wealth Advisors's Oracle position peaked at $478K in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.